[HTML][HTML] Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated …
…, L González-González, L Madrenas, I Güell… - The Lancet Regional …, 2023 - thelancet.com
Background A SARS-CoV-2 protein-based heterodimer vaccine, PHH-1V, has been shown
to be safe and well-tolerated in healthy young adults in a first-in-human, Phase I/IIa study …
to be safe and well-tolerated in healthy young adults in a first-in-human, Phase I/IIa study …
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
…, A Barreiro, L Gonzalez-Gonzalez, L Madrenas, I Guell… - medRxiv, 2024 - medrxiv.org
The HIPRA-HH-2 was a multicentre, randomized, active-controlled, double-blind, non-inferiority
phase IIb clinical trial to compare the immunogenicity and safety of a heterologous …
phase IIb clinical trial to compare the immunogenicity and safety of a heterologous …
Reactogenicity of Third and Fourth Booster Doses of Hipra Phh-1v, an Adjuvanded Bivalent Recombinant Protein Vaccine Against Sars-Cov-2
S de Cambra, J Corominas, I Güell, L Ferrer… - 17TH VACCINE … - papers.ssrn.com
Introduction: PHH-1V (Bimervax®, HIPRA), a recently granted EMA marketing authorisation
vaccine, is based on the receptor binding domain of two SARS-CoV-2 variants, Beta and …
vaccine, is based on the receptor binding domain of two SARS-CoV-2 variants, Beta and …
Humoral Immune Response Against Xbb. 1.5 and Bq. 1.1 Sars-Cov-2 Variants of a Fourth Dose of Phh-1v Vaccine in Adult Subject: Preliminary Results of Hipra-Hh-2 …
A Prenafeta, J Corominas, I Güell, MT Prat… - 17TH VACCINE …, 2023 - papers.ssrn.com
Background: In 2023, COVID-19 cases were mainly associated with BQ. 1 and XBB. 1.5
subvariants, causing mostly mild cases and boosting hybrid immunity throughout the population. …
subvariants, causing mostly mild cases and boosting hybrid immunity throughout the population. …
Changes in leg vein filling and emptying characteristics and leg volumes during long-term head-down bed rest
F Louisy, P Schroiff, A Guell - Journal of Applied Physiology, 1997 - journals.physiology.org
… Antonio Güell … Louisy, Francis, Philippe Schroiff, and Antonio Güell.Changes in leg vein
filling and emptying characteristics and leg volumes during long-term head-down bed rest. J. …
filling and emptying characteristics and leg volumes during long-term head-down bed rest. J. …
Related factors to semi-recumbent position compliance and pressure ulcers in patients with invasive mechanical ventilation: An observational study (CAPCRI study)
…, J Fernandez-Ballart, R Guell-Baro… - International Journal of …, 2016 - Elsevier
Background Semi-recumbent position is recommended to prevent ventilator-associated
pneumonia. Its implementation, however, is below optimal. Objectives We aimed to assess real …
pneumonia. Its implementation, however, is below optimal. Objectives We aimed to assess real …
[PDF][PDF] Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against …
J Corominas Garcia, C Garriga, A Prenafeta, A Moros… - 2023 - scientiasalut.gencat.cat
Background: A SARS-CoV-2 protein-based heterodimer vaccine, PHH-1V, has been shown
to be safe and well-tolerated in healthy young adults in a first-in-human, Phase I/IIa study …
to be safe and well-tolerated in healthy young adults in a first-in-human, Phase I/IIa study …
[HTML][HTML] Respiratory muscle training program supplemented by a cell-phone application in COPD patients with severe airflow limitation
BP Irina, MM Steluta, T Emanuela, M Diana… - Respiratory …, 2021 - Elsevier
Purpose The purpose of this study was to implement a respiratory muscle training program
through a mobile phone application for COPD patients with severe airflow limitation. Methods …
through a mobile phone application for COPD patients with severe airflow limitation. Methods …
[HTML][HTML] Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
L Leal, J Pich, L Ferrer, J Nava, R Martí-Lluch… - npj Vaccines, 2023 - nature.com
In response to COVID-19 pandemic, we have launched a vaccine development program
against SARS-CoV-2. Here we report the safety, tolerability, and immunogenicity of a …
against SARS-CoV-2. Here we report the safety, tolerability, and immunogenicity of a …
Use of Glargine in Women With Pregestational Diabetes and Neonatal Outcome
MC Hoffman, S Jeffers, G Guell, A Fajardo… - Obstetrics & …, 2006 - journals.lww.com
OBJECTIVE: To assess neonatal outcomes in women who use glargine during pregnancy for
control of pregestational diabetes. MATERIALS AND METHODS: A retrospective review of …
control of pregestational diabetes. MATERIALS AND METHODS: A retrospective review of …